Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shintaro Kinugawa

Showing results (51-60 of 195) with videos related to

Pageof 20
Sort By:
Circulation|February 21, 2002
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarctionShunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, et al.
BMC Pharmacology & Toxicology|May 8, 2021
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in miceTakaaki Furihata, Satoshi Maekawa, Shingo Takada, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2006
Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overloadHidenori Matsusaka, Tomomi Ide, Shouji Matsushima, et al.
Cardiovascular Research|March 15, 2006
Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in miceHidenori Matsusaka, Tomomi Ide, Shouji Matsushima, et al.
Skeletal Muscle|April 27, 2020
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction miceNaoya Kakutani, Shingo Takada, Hideo Nambu, et al.
The FEBS Journal|July 10, 2007
Fatty acids increase the circulating levels of oxidative stress factors in mice with diet-induced obesity via redox changes of albuminMayumi Yamato, Takeshi Shiba, Masayoshi Yoshida, et al.
Journal of Cardiovascular Pharmacology|October 13, 2006
Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarctionHidenori Matsusaka, Shintaro Kinugawa, Tomomi Ide, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2012
Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD)Sanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, et al.
Journal of Cardiology|September 12, 2013
Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failureSanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 10, 2005
Transcriptional basis for exercise limitation in male eNOS-knockout mice with age: heart failure and the fetal phenotypeCaroline Ojaimi, Wei Li, Shintaro Kinugawa, et al.
Pageof 20

Showing results (51-60 of 195) with videos related to

Sort By:
Pageof 20
Circulation|February 21, 2002
Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarctionShunji Hayashidani, Hiroyuki Tsutsui, Tetsuya Shiomi, et al.
BMC Pharmacology & Toxicology|May 8, 2021
Premedication with pioglitazone prevents doxorubicin-induced left ventricular dysfunction in miceTakaaki Furihata, Satoshi Maekawa, Shingo Takada, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2006
Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overloadHidenori Matsusaka, Tomomi Ide, Shouji Matsushima, et al.
Cardiovascular Research|March 15, 2006
Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in miceHidenori Matsusaka, Tomomi Ide, Shouji Matsushima, et al.
Skeletal Muscle|April 27, 2020
Angiotensin-converting-enzyme inhibitor prevents skeletal muscle fibrosis in myocardial infarction miceNaoya Kakutani, Shingo Takada, Hideo Nambu, et al.
The FEBS Journal|July 10, 2007
Fatty acids increase the circulating levels of oxidative stress factors in mice with diet-induced obesity via redox changes of albuminMayumi Yamato, Takeshi Shiba, Masayoshi Yoshida, et al.
Journal of Cardiovascular Pharmacology|October 13, 2006
Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarctionHidenori Matsusaka, Shintaro Kinugawa, Tomomi Ide, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 6, 2012
Loop diuretic use at discharge is associated with adverse outcomes in hospitalized patients with heart failure: a report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD)Sanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, et al.
Journal of Cardiology|September 12, 2013
Hyponatremia is an independent predictor of adverse clinical outcomes in hospitalized patients due to worsening heart failureSanae Hamaguchi, Shintaro Kinugawa, Miyuki Tsuchihashi-Makaya, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 10, 2005
Transcriptional basis for exercise limitation in male eNOS-knockout mice with age: heart failure and the fetal phenotypeCaroline Ojaimi, Wei Li, Shintaro Kinugawa, et al.
Pageof 20